Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s361405
Abstract: Background Clozapine (CLZ) is used for treatment-resistant schizophrenia (TRS). Adverse reactions to clozapine include neutropenia. In March 2020, WHO declared the COVID-19 pandemic and after, psychiatrists raised concerns regarding continuation of clozapine, due to multiple… read more here.
Keywords: infection; patients schizophrenia; clozapine neutropenia; clozapine ... See more keywords